Nurix Therapeutics Overview
Nurix Therapeutics Target Price
Analysts' average 12-month price target for Nurix Therapeutics is $34.
Get informed when a big investor buys or sells
+ FollowShare Price
$27.19
Average Target Price
$34.08
25.3% upside
25.3% upside13 analysts in the last 4 months
High: $45 | Low: $23
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-28 | Morgan Stanley | $38 | 39.8% upside |  |
| 2026-07-22 | UBS | $31 | 14% upside | |
| 2026-07-13 | Mizuho SecuritiesJoseph Catanzaro | $34 | 25% upside | |
| 2026-07-10 | RBC Capital | $33 | 21.4% upside | |
| 2026-07-10 | Truist FinancialGregory Renza | $34 | 25% upside | |
| 2026-07-10 | Stifel Nicolaus | $40 | 47.1% upside | |
| 2026-07-10 | H.C. Wainwright | $34 | 25% upside | |
| 2026-06-18 | Robert W. Baird | $33 | 21.4% upside | |
| 2026-06-09 | UBSDavid Dai | $23 |  15.4% downside | |
| 2026-06-09 | BTIGJeet Mukherjee | $32 | 17.7% upside | |
| 2026-06-08 | Truist Financial | $32 | 17.7% upside | |
| 2026-06-08 | JefferiesRoger Song | $45 | 65.5% upside | |
| 2026-06-08 | Needham | $34 | 25% upside | |
| 2026-04-09 | Wells Fargo | $28 | 3% upside | |
| 2026-01-29 | Stifel Nicolaus | $35 | 28.7% upside | |
| 2026-01-29 | Wells FargoDerek Archila | $29 | 6.7% upside | |
| 2026-01-29 | H.C. Wainwright | $32 | 17.7% upside | |
| 2026-01-08 | Morgan Stanley | $36 | 32.4% upside | |
| 2025-12-10 | H.C. WainwrightRobert Burns | $31 | 14% upside | |
| 2025-12-09 | BTIG | $30 | 10.3% upside | |
| 2025-11-24 | Truist Financial | $30 | 10.3% upside | |
| 2025-10-28 | H.C. Wainwright | $28 | 3% upside | |
| 2025-10-23 | BTIG | $27 | 0.7% downside | |
| 2025-10-23 | Wells Fargo | $21 | 22.8% downside | |
| 2025-10-22 | RBC CapitalGregory Renza | $29 | 6.7% upside | |
| 2025-10-14 | H.C. Wainwright | $33 | 21.4% upside | |
| 2025-10-13 | Wells Fargo | $22 | 19.1% downside | |
| 2025-10-10 | Stifel Nicolaus | $33 | 21.4% upside | |
| 2025-10-10 | OppenheimerMatthew Biegler | $28 | 3% upside | |
| 2025-10-10 | Piper Sandler | $32 | 17.7% upside | |
| 2025-07-15 | Morgan StanleyTerence Flynn | $16 | 41.2% downside | |
| 2025-07-10 | OppenheimerMatthew Biegler | $30 | 10.3% upside | |
| 2025-03-17 | Leerink Partners | $16 | 41.2% downside | |
| 2025-02-03 | Morgan StanleyTerence Flynn | $17 | 37.5% downside | |
| 2024-12-05 | BMO CapitalEtzer Darout | $35 | 28.7% upside | |
| 2024-10-24 | UBSDavid Dai | $35 | 28.7% upside | |
| 2024-10-21 | H.C. WainwrightRobert Burns | $30 | 10.3% upside | |
| 2024-10-15 | OppenheimerMatthew Biegler | $35 | 28.7% upside | |
| 2024-10-15 | Wells FargoDerek Archila | $32 | 17.7% upside | |
| 2024-10-14 | Stifel NicolausStephen Willey | $34 | 25% upside | |
| 2024-10-11 | JefferiesRoger Song | $41 | 50.8% upside | |
| 2024-09-05 | Robert W. BairdBrian Skorney | $26 | 4.4% downside | |
| 2024-08-14 | OppenheimerMatthew Biegler | $27 | 0.7% downside | |
| 2024-06-27 | RBC CapitalGregory Renza | $26 | 4.4% downside | |
| 2024-06-18 | H.C. WainwrightRobert Burns | $26 | 4.4% downside | |
| 2024-06-05 | Piper SandlerTyler Van Buren | $35 | 28.7% upside | |
| 2024-04-11 | RBC CapitalGregory Renza | $23 | 15.4% downside | |
| 2024-04-11 | Robert W. BairdJoel Beatty | $25 | 8.1% downside | |
| 2022-12-13 | Leerink Partners | $28 | 3% upside | |
| 2022-05-31 | Wells FargoDerek Archila | $25 | 8.1% downside | |